A Broward Health weight-loss drug has caught the attention of the FDA after regulators found it contained a drug that was pulled from the market more than a decade ago because it could pose serious health risks.
On Wednesday, the FDA advised against buying or using Alfia weight loss capsules sold online and in some retail stores.
Alfia, based in Hollywood at 3001 S Ocean Dr., sells weight-management pills, vitamin boosters and diet pills, according to its website.
An FDA laboratory analysis confirmed findings that the weight-loss drug contained sibutramine, a controlled substance that was pulled from the market in 2010 for safety reasons, the FDA said.
The pill “poses a risk” to consumers because sibutramine is known to significantly increase blood pressure and/or heart rate in some individuals and may be harmful to people with a history of coronary artery disease, congestive heart failure, cardiac arrhythmia or stroke Humans pose a significant risk.
The FDA said the pill could be life-threatening if mixed with other drugs.
The Herald has sought comment from businesses but has been unsuccessful.
People who have this product should report adverse side effects to FDA's MedWatch Safety Information and Adverse Event Reporting Program using one of the following methods:
▪ Complete and submit the report online in the MedWatch Online Voluntary Reporting Form
▪ download and finish formand submit by fax at 1-800-FDA-0178.
